Breast cancer is one of the leading causes of death within the United States. Today we're using cutting edge technology such as AI algorithm to achieve better patient outcomes in detecting and diagnosing breast cancers. Israel is evolving into an important hub that champions healthcare innovation and technology.
Our vision is to be the most innovative, valuable and inclusive partner in addressing the challenges facing healthcare today. We're excited to provide the global healthcare community with an opportunity to help us push the industry thought leadership in detection of breast cancer recurrence, oncological characterization, and evaluating associated treatment efficacy.
Our de-indetified data treasure trove
Expansive and careful collection of data
Data on people with breast cancer
The challenge tasked teams to create an algorithm for oncological, claims, labs and pharmacy data that predicts the probability of breast cancer recurrence. The winning teams are working with Anthem to fine-tune and pilot their models while receiving exposure to Anthem leadership and mentorship opportunities.
A panel of 11 judges from the Israeli HealthTech ecosystem and Anthem Digital rated the challenge participants' models based on novelty, innovative use of data provided, technical elegance and clinical value and impact on Anthem members.
The two winning teams, Clalit Research Institute and Generation Gap, will now have the opportunity to work with Anthem to run a pilot of their model, gain exposure to the U.S. healthcare system, and receive mentorship from Anthem executives and industry experts.
Using the Digital Data Sandbox, Anthem's expansive collection of certified de-identified oncological, claims, lab and pharmacy data, the challenge winners were able to build algorithms and validate their solutions.
The team created an app to help doctors make decisions regarding breast cancer adjuvants (treatment applied after initial cancer treatment to suppress the formation of secondary tumors). Based on a patient's medical data, the app predicts the probabilities of recurrence and bone fracture per each potential treatment.
Because of the negative side effects of chemotherapy, some women consider skipping their final treatments. The team developed a model to identify if there was association between recurrence of a specific type of aggressive breast cancer and the completion of a full chemotherapy regimen.
The Data Sandbox is Anthem's free rapid insights discovery engine that enables solutions to some of healthcare's most complex problems. Find out how you can request access to build and train algorithms, validate solutions with Anthem experts and deploy those solutions in the real world.Learn More